![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Mac Chem Products (india) Pvt. Ltd. Mumbai In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Expertise in Development & Commercialisation of Oncology APIs.
One of their significant offerings is Gefitinib, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2017-164 - Rev 00
This Chemical Type CEP, issued on March 27, 2019, remains in force until April 24, 2023, ensuring its reliability within the pharmaceutical industry.
Substance Number 2866 associated with this CEP further emphasizes